Dynavax Technologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2000
Net Income	9.22	-6.39	292.87	72.14	-75.24	-155.87	Upgrade
Depreciation & Amortization	7.57	7.28	6.67	7.06	6.84	12.31	Upgrade
Share-Based Compensation	45.57	42.59	32.92	21.29	13.48	25.46	Upgrade
Other Operating Activities	-6.1	57.08	-270.02	230.47	-37.33	-6.42	Upgrade
Operating Cash Flow	56.26	100.56	62.72	335.53	-92.25	-121.25	Upgrade
Operating Cash Flow Growth	-60.04%	60.35%	-81.31%	-	-	-	Upgrade
Capital Expenditures	-2.57	-3.1	-6.14	-8.48	2.78	-22.4	Upgrade
Change in Investments	-96.19	-150.82	-309.86	22.7	-22.31	-13.38	Upgrade
Other Investing Activities	-	-	-	-	-7	-7	Upgrade
Investing Cash Flow	-98.76	-153.93	-316	14.23	-26.53	-42.78	Upgrade
Share Issuance / Repurchase	9.42	7.9	11.07	35.57	109.5	66.52	Upgrade
Debt Issued / Paid	0	0	0	29.63	0	74.25	Upgrade
Other Financing Activities	-9.15	-6.51	8.46	-9.43	-	13.59	Upgrade
Financing Cash Flow	0.27	1.39	19.53	55.78	109.5	154.35	Upgrade
Exchange Rate Effect	-0.03	0.32	-0.44	-1.43	1.49	-0.18	Upgrade
Net Cash Flow	-42.26	-51.66	-234.2	404.1	-7.79	-9.87	Upgrade
Free Cash Flow	53.69	97.46	56.58	327.05	-89.47	-143.65	Upgrade
Free Cash Flow Growth	-60.14%	72.26%	-82.70%	-	-	-	Upgrade
Free Cash Flow Margin	22.74%	41.96%	7.83%	74.42%	-192.20%	-407.88%	Upgrade
Free Cash Flow Per Share	0.41	0.76	0.45	2.81	-0.89	-2.00	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).